Mike Dawson Antimicrobial Research Consultancy Ltd.

Mike Dawson Antimicrobial Research Consultancy Ltd.Mike Dawson Antimicrobial Research Consultancy Ltd.Mike Dawson Antimicrobial Research Consultancy Ltd.

Mike Dawson Antimicrobial Research Consultancy Ltd.

Mike Dawson Antimicrobial Research Consultancy Ltd.Mike Dawson Antimicrobial Research Consultancy Ltd.Mike Dawson Antimicrobial Research Consultancy Ltd.
More

Experienced industry scientist, former Biotech CSO/CEO

Antibacterials

Small company development

Experience

A biochemist by training Mike worked for 20 years in GSK (Glaxo, Glaxo Wellcome) mostly in the natural product area. In 2003 he cofounded Novacta Biosystems Limited where as CSO he led the development of a semi-synthetic lantibiotic NVB302 into the clinic for C. difficile infection. From 2012 - 2017 as CEO of Cantab Anti-infectives Mike led the company through the successful development of improved polymyxin analogues now progressing with Spero Therapeutics Inc. Mike brings a wealth of experience in antibacterials as well as in all aspects of running a small company.

Services

Opportunity evaluation/assessment

Business start up/Business plan development

Project management

Grant applications 

Programme/portfolio review

Contact Us

Send Message

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Copyright © 2018 Mike Dawson Antimicrobial Research Consultancy Ltd. - All Rights Reserved.

Powered by GoDaddy

  • Privacy Policy